Literature DB >> 30371657

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma.

Aaron Abajian1, Nikitha Murali2, Lynn Jeanette Savic3, Fabian Max Laage-Gaupp2, Nariman Nezami2, James S Duncan4, Todd Schlachter2, MingDe Lin5, Jean-François Geschwind6, Julius Chapiro7.   

Abstract

Intra-arterial therapies are the standard of care for patients with hepatocellular carcinoma who cannot undergo surgical resection. The objective of this study was to develop a method to predict response to intra-arterial treatment prior to intervention. The method provides a general framework for predicting outcomes prior to intra-arterial therapy. It involves pooling clinical, demographic and imaging data across a cohort of patients and using these data to train a machine learning model. The trained model is applied to new patients in order to predict their likelihood of response to intra-arterial therapy. The method entails the acquisition and parsing of clinical, demographic and imaging data from N patients who have already undergone trans-arterial therapies. These data are parsed into discrete features (age, sex, cirrhosis, degree of tumor enhancement, etc.) and binarized into true/false values (e.g., age over 60, male gender, tumor enhancement beyond a set threshold, etc.). Low-variance features and features with low univariate associations with the outcome are removed. Each treated patient is labeled according to whether they responded or did not respond to treatment. Each training patient is thus represented by a set of binary features and an outcome label. Machine learning models are trained using N - 1 patients with testing on the left-out patient. This process is repeated for each of the N patients. The N models are averaged to arrive at a final model. The technique is extensible and enables inclusion of additional features in the future. It is also a generalizable process that may be applied to clinical research questions outside of interventional radiology. The main limitation is the need to derive features manually from each patient. A popular modern form of machine learning called deep learning does not suffer from this limitation, but requires larger datasets.

Entities:  

Mesh:

Year:  2018        PMID: 30371657      PMCID: PMC6235502          DOI: 10.3791/58382

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

3.  EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.

Authors:  Roopinder Gillmore; Sam Stuart; Amy Kirkwood; Ayshea Hameeduddin; Nick Woodward; Andrew K Burroughs; Tim Meyer
Journal:  J Hepatol       Date:  2011-04-15       Impact factor: 25.083

Review 4.  Machine learning and radiology.

Authors:  Shijun Wang; Ronald M Summers
Journal:  Med Image Anal       Date:  2012-02-23       Impact factor: 8.545

5.  Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.

Authors:  Aaron Abajian; Nikitha Murali; Lynn Jeanette Savic; Fabian Max Laage-Gaupp; Nariman Nezami; James S Duncan; Todd Schlachter; MingDe Lin; Jean-François Geschwind; Julius Chapiro
Journal:  J Vasc Interv Radiol       Date:  2018-03-14       Impact factor: 3.464

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

8.  Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

Authors:  MingDe Lin; Olivier Pellerin; Nikhil Bhagat; Pramod P Rao; Romaric Loffroy; Roberto Ardon; Benoit Mory; Diane K Reyes; Jean-François Geschwind
Journal:  J Vasc Interv Radiol       Date:  2012-12       Impact factor: 3.464

9.  Application of support vector machine for prediction of medication adherence in heart failure patients.

Authors:  Youn-Jung Son; Hong-Gee Kim; Eung-Hee Kim; Sangsup Choi; Soo-Kyoung Lee
Journal:  Healthc Inform Res       Date:  2010-12-31

10.  Development of machine learning models for diagnosis of glaucoma.

Authors:  Seong Jae Kim; Kyong Jin Cho; Sejong Oh
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

View more
  3 in total

Review 1.  Artificial intelligence in gastroenterology and hepatology: Status and challenges.

Authors:  Jia-Sheng Cao; Zi-Yi Lu; Ming-Yu Chen; Bin Zhang; Sarun Juengpanich; Jia-Hao Hu; Shi-Jie Li; Win Topatana; Xue-Yin Zhou; Xu Feng; Ji-Liang Shen; Yu Liu; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

2.  Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial Chemoembolization.

Authors:  Yuze Li; Ziming Xu; Chao An; Huijun Chen; Xiao Li
Journal:  J Pers Med       Date:  2022-02-09

Review 3.  Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review.

Authors:  Miguel Jiménez Pérez; Rocío González Grande
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.